Saskatchewan judge certifies Vioxx class action

A Canadian court has certified a big Vioxx class-action case to include any Canadian patients outside of Quebec; Merck is appealing that decision and vows to fight the entire case, saying that every plaintiff will still have to prove the facts of his or her individual Vioxx side effects. Report

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.